Noble Superspeciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 27-06-2024
- Paid Up Capital ₹ 1.01 Cr
as on 27-06-2024
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.85 Cr
as on 27-06-2024
- Revenue 1301.11%
(FY 2023)
- Profit 240.01%
(FY 2023)
- Ebitda 2318.76%
(FY 2023)
- Net Worth 37.44%
(FY 2023)
- Total Assets 7.80%
(FY 2023)
About Noble Superspeciality Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.01 Cr.
The company currently has active open charges totaling ₹9.85 Cr.
Anil Jain and Poonam Jain serve as directors at the Company.
- CIN/LLPIN
U85200UP2019PTC120060
- Company No.
120060
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Aug 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Kanpur, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Noble Superspeciality Hospital?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Poonam Jain  | Managing Director | 09-Aug-2019 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Jain | Director | 09-Aug-2019 | Current |
Financial Performance of Noble Superspeciality Hospital.
Noble Superspeciality Hospital Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1301.11% increase. The company also saw a substantial improvement in profitability, with a 240.01% increase in profit. The company's net worth Soared by an impressive increase of 37.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Noble Superspeciality Hospital?
In 2023, Noble Superspeciality Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anupam (Excellent) Healthcare LlpActive 7 years 9 monthsAnil Jain and Poonam Jain are mutual person
- Alpha Imaging And Research Institute Private LimitedActive 16 years 3 months
Anil Jain is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 03 Feb 2021 | ₹9.85 Cr | Open |
How Many Employees Work at Noble Superspeciality Hospital?
Noble Superspeciality Hospital has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Noble Superspeciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noble Superspeciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
